Philips VS3 Vital Suresigns Monitor w/ NBP SpO2 Temp Certified w/90 day Warranty

Philips VS3 Vital Suresigns Monitor w/ NBP SpO2 Temperature with printer 863047 Because the SureSigns VS3 user interface is intuitive and easy to use, you can focus on what matters most — patient care and comfort. The SureSigns VS3 offers peace of mind and flexibility, in a package that's as easy to love as it is to use.

• Model: 863047

Features:
• Display Screen Size: 20.3cm
• NBP:
• Adult/ Pediatric Measurement Range: Systolic - 30-255mmHg; Diastolic - 15-220 mmHg; Mean - 20-235 mmHg
• Neonatal Measurement Range: Systolic - 30-135 mmHg, Diastolic - 15-110 mmHg; Mean - 20-125 mmHg
• Blood Pressure Accuracy: +/- 5mmHg
• Pulse Rate Accuracy: +/- 2 bpm
• Time-saving features to simplify tasks
• The innovative pop-up screens, fixed keys, and icon-based menus provide quick access to frequently used features. A trim knob offers easy navigation through settings.
• Improved battery management clearly shows the status
• A clearly visible icon is lit when the battery is plugged in/charged so that caregivers can easily see when the device is available.
• Scrollable list of patient records stores up to 400 records
• Easily scroll to your patient's record. Up to 400 patient records can be stored on this monitor.
• QuickCheck to simplify workflow
• Caregiver authentication and patient record validation at the bedside, plus patient record review before export to EHR simplifies clinician workflow.

Certified by Qualified Service Entity (CQSE):

This medical equipment item has been certified by a service entity skilled or trained to work specifically on this type of device. The certification process may involve repair with replacement parts, calibration, and the periodic maintenance recommended by the original manufacturer. Additionally, cosmetic work and cleaning may have been performed to enhance the visual appeal of the equipment. This ensures that the equipment not only meets operational standards but also maintains a visually pleasing appearance.

MP/03/24/2025